|
|
|
 |
|
| Probability of Developing Invasive Cancers within Selected Age Intervals, by Gender, US, 1995-1997* |
|
|
TABLE 3
CA Cancer J Clin 2001;51:19 |
|
|
|
|
Birth to 39 |
40 to 59 |
60 to 79 |
Birth to Death |
|
|
|
% |
% |
% |
% |
| |
| All sites ** |
Male |
1.56 (1 in 64) |
8.25 (1 in 12) |
33.13 (1 in 3) |
43.48 (1 in 2) |
|
Female |
1.97 (1 in 51) |
9.37 (1 in 11) |
22.39 (1 in 4) |
38.34 (1 in 3) |
| |
| Bladder*** |
Male |
0.03 (1 in 3,437) |
0.44 (1 in 226) |
2.39 (1 in 42) |
3.40 (1 in 29) |
|
Female |
(Less than 1 in 10,000) |
0.14 (1 in 699) |
0.68 (1 in 146) |
1.18 (1 in 85) |
| |
| Breast |
Female |
0.44 (1 in 225) |
4.15 (1 in 24) |
7.02 (1 in 14) |
12.83 (1 in 8) |
| |
| Colon & Rectum |
Male |
0.07 (1 in 1,531) |
0.87 (1 in 115) |
4.00 (1 in 25) |
5.78 (1 in 17) |
|
Female |
0.05 (1 in 1,855) |
0.69 (1 in 146) |
3.04 (1 in 33) |
5.55 (1 in 18) |
| |
| Leukemia |
Male |
0.15 (1 in 654) |
0.21 (1 in 467) |
0.84 (1 in 119) |
1.42 (1 in 70) |
|
Female |
0.11 (1 in 900) |
0.15 (1 in 671) |
0.50 (1 in 199) |
1.05 (1 in 95) |
| |
| Lung & |
Male |
0.04 (1 in 2,499) |
1.24 (1 in 80) |
6.29 (1 in 16) |
8.09 (1 in 12) |
| |
| Bronchus |
Female |
0.03 (1 in 2,997) |
0.92 (1 in 108) |
4.04 (1 in 25) |
5.78 (1 in 17) |
| |
| Melanoma |
Male |
0.13 (1 in 744) |
0.53 (1 in 190) |
0.94 (1 in 106) |
1.68 (1 in 60) |
|
Female |
0.22 (1 in 453) |
0.40 (1 in 249) |
0.48 (1 in 207) |
1.25 (1 in 80) |
| |
| Non-Hodgkin's |
Male |
0.19 (1 in 513) |
0.50 (1 in 198) |
1.21 (1 in 83) |
2.11 (1 in 47) |
| |
| Lymphoma |
Female |
0.08 (1 in 1,296) |
0.32 (1 in 312) |
0.97 (1 in 103) |
1.74 (1 in 57) |
| |
| Prostate |
Male |
(Less than 1 in 10,000) |
2.06 (1 in 49) |
13.42 (1 in 7) |
15.89 (1 in 6) |
| |
| Uterine Cervix |
Female |
0.17 (1 in 576) |
0.30 (1 in 332) |
0.26 (1 in 387) |
0.78 (1 in 129) |
| |
| Uterine Corpus |
Female |
0.05 (1 in 2,142) |
0.74 (1 in 136) |
1.67 (1 in 60) |
2.73 (1 in 37) |
* For those free of cancer at beginning of age interval. Based on cancer cases diagnosed between 1995 and 1997.
The "1 in" statistic and the inverse of the percentage may not be equivalent due to rounding.
†All sites excludes basal and squamous cell skin cancers and in situ cancers except urinary bladder.
‡Includes invasive and in situ cancer cases.
Data Source: DEVCAN Software, Version 4.0, Surveillance, Epidemiology, and End Results Program, 1973-1997, Division of Cancer Control and Population Sciences, National Cancer Institute, 2000.
|
|
|
|
|
